Veeva Systems Inc. (0LO3.L)
USD 216.72
(-1.25%)
USD 216.72
(-1.25%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 2.36 Billion USD | 9.68% |
| 2023 | 2.15 Billion USD | 16.44% |
| 2022 | 1.85 Billion USD | 26.33% |
| 2021 | 1.46 Billion USD | 32.7% |
| 2020 | 1.1 Billion USD | 28.05% |
| 2019 | 862.21 Million USD | 25.77% |
| 2018 | 685.57 Million USD | 26.01% |
| 2017 | 544.04 Million USD | 32.95% |
| 2016 | 409.22 Million USD | 30.65% |
| 2015 | 313.22 Million USD | 49.05% |
| 2014 | 210.15 Million USD | 62.22% |
| 2013 | 129.54 Million USD | 111.47% |
| 2012 | 61.26 Million USD | 110.31% |
| 2011 | 29.12 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 630.61 Million USD | 2.29% |
| 2024 Q1 | 526.32 Million USD | -6.58% |
| 2024 Q2 | 590.22 Million USD | 12.14% |
| 2024 FY | 2.36 Billion USD | 9.68% |
| 2024 Q3 | 616.5 Million USD | 4.45% |
| 2023 Q3 | 552.35 Million USD | 3.39% |
| 2023 Q1 | 505.1 Million USD | 4.04% |
| 2023 FY | 2.15 Billion USD | 16.44% |
| 2023 Q2 | 534.21 Million USD | 5.76% |
| 2023 Q4 | 563.38 Million USD | 2.0% |
| 2022 Q4 | 485.49 Million USD | 1.97% |
| 2022 Q2 | 455.59 Million USD | 5.08% |
| 2022 Q1 | 433.57 Million USD | 9.28% |
| 2022 FY | 1.85 Billion USD | 26.33% |
| 2022 Q3 | 476.11 Million USD | 4.5% |
| 2021 Q4 | 396.76 Million USD | 5.1% |
| 2021 FY | 1.46 Billion USD | 32.7% |
| 2021 Q1 | 337.1 Million USD | 8.22% |
| 2021 Q3 | 377.51 Million USD | 6.74% |
| 2021 Q2 | 353.68 Million USD | 4.92% |
| 2020 Q1 | 244.75 Million USD | 5.35% |
| 2020 Q3 | 280.92 Million USD | 5.25% |
| 2020 FY | 1.1 Billion USD | 28.05% |
| 2020 Q4 | 311.5 Million USD | 10.89% |
| 2020 Q2 | 266.9 Million USD | 9.05% |
| 2019 FY | 862.21 Million USD | 25.77% |
| 2019 Q4 | 232.32 Million USD | 3.38% |
| 2019 Q3 | 224.73 Million USD | 7.21% |
| 2019 Q2 | 209.6 Million USD | 7.19% |
| 2019 Q1 | 195.54 Million USD | 5.75% |
| 2018 FY | 685.57 Million USD | 26.01% |
| 2018 Q3 | 176.14 Million USD | 5.74% |
| 2018 Q4 | 184.91 Million USD | 4.98% |
| 2018 Q1 | 157.91 Million USD | 5.17% |
| 2018 Q2 | 166.58 Million USD | 5.49% |
| 2017 Q1 | 119.76 Million USD | 4.81% |
| 2017 Q4 | 150.15 Million USD | 5.16% |
| 2017 FY | 544.04 Million USD | 32.95% |
| 2017 Q3 | 142.77 Million USD | 8.7% |
| 2017 Q2 | 131.34 Million USD | 9.67% |
| 2016 Q2 | 98.1 Million USD | 9.1% |
| 2016 Q1 | 89.92 Million USD | 3.35% |
| 2016 FY | 409.22 Million USD | 30.65% |
| 2016 Q4 | 114.27 Million USD | 6.87% |
| 2016 Q3 | 106.92 Million USD | 8.98% |
| 2015 FY | 313.22 Million USD | 49.05% |
| 2015 Q4 | 87.01 Million USD | 3.8% |
| 2015 Q3 | 83.82 Million USD | 10.79% |
| 2015 Q2 | 75.66 Million USD | 13.4% |
| 2015 Q1 | 66.72 Million USD | 6.24% |
| 2014 Q2 | 49.58 Million USD | 15.88% |
| 2014 FY | 210.15 Million USD | 62.22% |
| 2014 Q3 | 54.97 Million USD | 10.89% |
| 2014 Q4 | 62.8 Million USD | 14.23% |
| 2014 Q1 | 42.78 Million USD | 7.54% |
| 2013 Q4 | 39.78 Million USD | 11.15% |
| 2013 Q3 | 35.79 Million USD | 0.0% |
| 2013 FY | 129.54 Million USD | 111.47% |
| 2012 FY | 61.26 Million USD | 110.31% |
| 2011 FY | 29.12 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -563.396% |
| Accuray Incorporated | 446.55 Million USD | -429.318% |
| Align Technology, Inc. | 3.86 Billion USD | 38.801% |
| Elevance Health Inc. | 171.34 Billion USD | 98.62% |
| AxoGen, Inc. | 159.01 Million USD | -1386.475% |
| Boston Scientific Corporation | 14.24 Billion USD | 83.401% |
| CVS Health Corporation | 357.77 Billion USD | 99.339% |
| Cardinal Health, Inc. | 226.82 Billion USD | 98.958% |
| Centene Corporation | 141.26 Billion USD | 98.327% |
| DaVita Inc. | 12.14 Billion USD | 80.53% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 96.362% |
| Hologic, Inc. | 4.03 Billion USD | 41.352% |
| Humana Inc. | 106.37 Billion USD | 97.778% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 35.436% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 80.564% |
| Masimo Corporation | 2.04 Billion USD | -15.408% |
| McKesson Corporation | 308.95 Billion USD | 99.235% |
| Patterson Companies, Inc. | 6.56 Billion USD | 64.014% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 74.452% |
| ResMed Inc. | 4.68 Billion USD | 49.551% |
| Henry Schein, Inc. | 12.33 Billion USD | 80.844% |
| Teladoc Health, Inc. | 2.6 Billion USD | 9.174% |
| Universal Health Services, Inc. | 14.28 Billion USD | 83.45% |
| Baxter International Inc. | 14.81 Billion USD | 84.043% |
| Becton, Dickinson and Company | 19.37 Billion USD | 87.799% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 66.821% |
| Danaher Corporation | 23.89 Billion USD | 90.106% |
| Stryker Corporation | 20.49 Billion USD | 88.469% |
| Medtronic plc | 32.36 Billion USD | 92.697% |